A detailed history of Roundview Capital LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Roundview Capital LLC holds 10,800 shares of ABT stock, worth $1.23 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
10,800
Previous 10,370 4.15%
Holding current value
$1.23 Million
Previous $1.08 Million 14.3%
% of portfolio
0.09%
Previous 0.09%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$100.07 - $118.13 $43,030 - $50,795
430 Added 4.15%
10,800 $1.23 Million
Q2 2024

Aug 09, 2024

SELL
$100.73 - $112.44 $67,489 - $75,334
-670 Reduced 6.07%
10,370 $1.08 Million
Q1 2024

May 06, 2024

BUY
$109.52 - $120.96 $157,818 - $174,303
1,441 Added 15.01%
11,040 $1.25 Million
Q4 2023

Feb 12, 2024

BUY
$90.19 - $110.4 $101,734 - $124,531
1,128 Added 13.32%
9,599 $1.06 Million
Q3 2023

Nov 13, 2023

SELL
$95.53 - $114.62 $955 - $1,146
-10 Reduced 0.12%
8,471 $820,000
Q2 2023

Aug 09, 2023

SELL
$100.78 - $112.29 $934,129 - $1.04 Million
-9,269 Reduced 52.22%
8,481 $924,000
Q1 2023

May 09, 2023

BUY
$96.86 - $114.01 $59,181 - $69,660
611 Added 3.56%
17,750 $1.8 Million
Q4 2022

Feb 13, 2023

BUY
$95.06 - $111.52 $34,601 - $40,593
364 Added 2.17%
17,139 $1.88 Million
Q3 2022

Nov 10, 2022

BUY
$96.76 - $112.03 $71,021 - $82,230
734 Added 4.58%
16,775 $1.62 Million
Q2 2022

Aug 11, 2022

BUY
$102.07 - $123.37 $44,604 - $53,912
437 Added 2.8%
16,041 $1.74 Million
Q1 2022

May 11, 2022

SELL
$114.02 - $139.04 $10,375 - $12,652
-91 Reduced 0.58%
15,604 $1.85 Million
Q4 2021

Feb 10, 2022

SELL
$115.53 - $141.46 $163,243 - $199,882
-1,413 Reduced 8.26%
15,695 $2.21 Million
Q3 2021

Nov 10, 2021

BUY
$116.66 - $129.06 $268,667 - $297,225
2,303 Added 15.56%
17,108 $2.02 Million
Q2 2021

Aug 10, 2021

SELL
$105.79 - $124.53 $17,878 - $21,045
-169 Reduced 1.13%
14,805 $1.72 Million
Q1 2021

May 14, 2021

BUY
$108.84 - $128.23 $26,665 - $31,416
245 Added 1.66%
14,974 $1.8 Million
Q4 2020

Feb 08, 2021

BUY
$105.0 - $114.42 $71,820 - $78,263
684 Added 4.87%
14,729 $1.61 Million
Q3 2020

Nov 05, 2020

BUY
$91.64 - $111.29 $625,809 - $759,999
6,829 Added 94.64%
14,045 $1.53 Million
Q2 2020

Aug 13, 2020

BUY
$76.57 - $98.0 $32,465 - $41,552
424 Added 6.24%
7,216 $660,000
Q1 2020

May 11, 2020

BUY
$62.82 - $91.86 $20,542 - $30,038
327 Added 5.06%
6,792 $536,000
Q2 2019

Aug 12, 2019

SELL
$72.88 - $85.0 $145,832 - $170,085
-2,001 Reduced 23.64%
6,465 $543,000
Q1 2019

May 09, 2019

BUY
$66.22 - $80.06 $7,151 - $8,646
108 Added 1.29%
8,466 $677,000
Q4 2018

Feb 13, 2019

BUY
$65.56 - $74.27 $137,872 - $156,189
2,103 Added 33.62%
8,358 $605,000
Q3 2018

Nov 07, 2018

SELL
$60.81 - $73.36 $3,952 - $4,768
-65 Reduced 1.03%
6,255 $459,000
Q1 2018

May 14, 2018

SELL
$56.27 - $63.62 $104,099 - $117,697
-1,850 Reduced 22.64%
6,320 $379,000
Q4 2017

Feb 07, 2018

SELL
$53.68 - $57.47 $5,368 - $5,747
-100 Reduced 1.21%
8,170 $466,000
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $10,813 - $12,069
225 Added 2.8%
8,270 $441,000
Q3 2017

Nov 13, 2017

BUY
$48.06 - $53.64 $386,642 - $431,533
8,045
8,045 $391,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Roundview Capital LLC Portfolio

Follow Roundview Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roundview Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Roundview Capital LLC with notifications on news.